For Immediate Release
Chicago, IL – May 09, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include United Technologies (NYSE: UTX – Free Report ), Lilly (NYSE: LLY – Free Report ), American Express (NYSE: AXP – Free Report ), Aetna (NYSE:AET) (NYSE: AET – Free Report ), Las Vegas Sands (NYSE: LVS – Free Report ) and Capital One (NYSE: COF – Free Report ).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Today UTX, LLY, AXP
Today's Research Daily features new research reports on 16 major stocks, including United Technologies (NYSE: UTX – Free Report ), Lilly (NYSE:LLY – Free Report ) and American Express (NYSE: AXP – Free Report ).
United Technologies shares have gained +10.2% over the last three months, higher than the +4.5% increase for the Zacks Conglomerates sector. The company recorded solid first-quarter 2017 results with healthy year-over-year increase in revenues and adjusted earnings that exceeded expectations. United Technologies also reaffirmed its guidance for 2017 on favorable growth dynamics.
The Zacks analyst likes the business mix and diversification which allows the company to deliver consistent earnings and dividend growth. The company is focused on revamping its aerospace unit to overhaul the organizational structure and accelerate inorganic growth through potential acquisition opportunities.
On the flip side, the company remains exposed to a weak global macroeconomic backdrop and uncertainty about the Trump administration's trade policy. Other issues include exposure to market price volatility and availability risks related to raw materials. (You can read the full research report on United Technologies here. )
Pharmaceutical stocks have been under pressure since last year on pricing and regulatory concerns but Eli Lilly shares have managed to buck the trend to some extent. The stock has outperformed its peer group; it is up +9.2% over the last 12 months vs. +2.8% for the Zacks Pharma industry and +2.5% for the Zacks Medical sector Lilly’s first-quarter 2017 results were mixed with earnings beating estimates but revenues missing.
But the Zacks analyst is encouraged by the fact that Lilly expects to launch 20 new products in a 10 year time-frame ranging from 2014 to 2023 and could launch at least 2 new indications/line extensions on average every year. Moreover, Lilly returned to annual dividend increases in Dec 2016 and is also returning excess cash through share buybacks. (You can read the full research report on Eli Lilly here. )
American Express ' first quarter earnings exceeded expectations but declined year over year. The company also continues to witness mounting loan loss provisions. Moreover, a strong U.S. dollar, loss of Costco (NASDAQ:COST) as a client and intense competition remain major near-term concerns. However, the company has raised its guidance for 2017.
Additionally, over the last year, the company has gained +22.4%, higher than the broader finance sector’s gain of +20.9%. The Zacks analyst also likes its solid market position, strength in card business and significant opportunities from the secular shift toward electronic payments. (You can read the full research report on American Express here. )
Other noteworthy reports we are featuring today include Aetna (NYSE: AET – Free Report ), Las Vegas Sands (NYSE: LVS – Free Report ) and Capital One (NYSE: COF – Free Report ).
Now See All Our Private Trades
While today's Zacks Rank #1 new additions are being shared with the public, other trades are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for all Zacks trades >>
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free .
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.
Get the full Report on UTX - FREE
Get the full Report on LLY - FREE
Get the full Report on AXP - FREE
Get the full Report on AET - FREE
Get the full Report on LVS - FREE
Get the full Report on COF - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook (NASDAQ:FB): https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
United Technologies Corporation (NYSE:UTX
Eli Lilly and Company (NYSE:LLY
American Express Company (NYSE:AXP
Las Vegas Sands Corp. (LVS): Free Stock Analysis Report
Capital One Financial Corporation (NYSE:COF
Original post
Zacks Investment Research